Blood-based genomic assessment is 90% accurate in predicting PRRT treatment response for NETs.
NETest is 4X more precise than CgA and 10X more precise for monitoring disease progress.
Wren Lab’s liquid biopsy has proven an effective biomarker for cancer treatment decision-making.
Noninvasive NETest-type diagnostics predict therapy success and provide therapy monitoring.
NETest is a highly accurate post-operative predictor of neuroendocrine tumor recurrence.
688 East Main Street, Branford, CT 06405